Oral Health in Children With Inflammatory Bowel Disease

September 11, 2022 updated by: Marmara University

Dental Caries, Dental Erosion and Periodontal Disease in Children With Inflammatory Bowel Disease

In adults with inflammatory bowel disease (IBD), a higher prevalence of dental caries and periodontal disease has been reported compared with healthy control subjects, but similar data on children are missing in the literature.We aimed to evaluate the prevalence of dental erosion, dental caries and periodontal disease in children with IBD.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In this age- and gender-matched prospective case-control study, detailed questionnaires including nutritional habits and oral examinations were completed for 32 IBD patients aged 11 to 18 (15,53±2,00 yr) and 32 healthy controls based on the established criteria of the World Health Organization by the same pediatric dentist.

Study Type

Observational

Enrollment (Actual)

64

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İstanbul, Turkey
        • Marmara University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Study population with inflammatory bowel disease in the remission period.

Description

Inclusion Criteria:

  • 11-18 years of age
  • Study population with IBD in the remission period of disease
  • Permanent dentition stage

Exclusion Criteria:

  • Those who refused or whose families refused participation in this study
  • Study population with IBD in the active period of disease
  • Primary or mix dentition stage
  • Systemic conditions, or medications with impact on periodontal tissues and previous orthodontic or periodontal treatment within the last year.
  • Smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with IBD
Patients with inflammatory bowel disease on remission period
Other: No intervention was given to the patients
This study was an observational epidemiological study.
Control
Age- and gender- matched healthy population
Other: No intervention was given to the patients
This study was an observational epidemiological study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dental caries
Time Frame: In one year
In the present study WHO criteria were used to detect DMFT (decayed, missing and filled permanent teeth) scores
In one year
Dental erosion
Time Frame: In one year
Dental erosion status was determined with the basic erosive wear examination (BEWE) index
In one year
Periodontal disease
Time Frame: In one year
The patients' and controls' gingival condition was also scored according to the criteria of a Gingival Index (GI) System. The oral hygiene status was determined with the PCR index in order to assess the presence or absence of marginal plaque. The prevalence and the severity of periodontal disease were recorded with the CPITN after dividing the oral cavity into sextants.
In one year
Oral extraintestinal manifestations (EIMs)
Time Frame: In one year
including the lip mucosa, buccal mucosa, gingiva; the palatal mucosa and oropharynx; the tongue dorsum, tongue ventrum, and floor of the mouth
In one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Marmara University

Collaborators

Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

June 15, 2022

Study Completion (Actual)

June 15, 2022

Study Registration Dates

First Submitted

September 11, 2022

First Submitted That Met QC Criteria

September 11, 2022

First Posted (Actual)

September 14, 2022

Study Record Updates

Last Update Posted (Actual)

September 14, 2022

Last Update Submitted That Met QC Criteria

September 11, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HDireskeneli

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oral Health in Children With Inflammatory Bowel Disease

Clinical Trials on No intervention was given to the patients

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe